Shasun Pharma’s performance has been highly erratic. However, the expectation that Shasun will benefit heavily as a result of the Sevelamer molecule drugs going off patent in the US has sent investors into a buying frenzy
Daljeet Kohli Stock Pick JB Chemicals Gives 69% Return In 6 Months
If you still haven’t grabbed a chunk of JB Chemicals, there is no need to despair because there is a lot of juice left. Daljeet also has a number of other top-quality stock picks you can consider
MRPL Spurts 17% But Is It Time To Be Cautious About Its’ Future
MRPL’s surge of 17% today vindicates the stand of some savvy stock pickers that if you time your purchase, you can make quick and hefty gains. However, the larger issue is whether MRPL will meet the same fate as its OMC cousins
Meet Punita & Jayant Sinha, The Fund Manager Power Couple Worth Rs. 55 Crore
Punita Kumar-Sinha and her spouse Jayant Sinha are a power couple in the field of investments and fund management. They are now set to play a pivotal role in the field of politics
Prof. Shivanand Mankekar, The Genius Stock Picker With A Concentrated Portfolio
Prof. Shivanand Mankekar’s stock market activities reveal him to be a person with extraordinary skill, vision, conviction and temperament. We explore his investment strategy
What Stocks Are Top Mutual Funds Buying And Selling?
IDBI Capital has compiled a list of the stocks that top Mutual Funds are buying and selling. The report gives a trend of which stocks are favourites and which are not
Centrum Picks Top Pharma Stocks With 30% Expected Return
Centrum Equity Research has conducted a comprehensive analysis of the best pharma companies & picked those with 30% expected return
Billionaire Ajay Piramal, the Contrarian Investor, Is Sending A Clear Message To Us With His Stock Picks
Ajay Piramal is a contrarian investor. His recent mega stock picks reveal a strategy of buying top quality stocks that are temporarily out of favour with investors. There is much that we can learn from the investment technique of this savvy investor
Daljeet Kohli’s Model Portfolio Gives 25% Return. New Stocks With Profit Potential Added
Daljeet Kohli’s Model Portfolio has reported a splendid performance and beaten the Benchmark by a wide margin. The Portfolio has now been shuffled by removing two stocks and adding two stocks
Best Large-Cap & Mid-Cap Pharma Stocks To Buy Now: Daljeet Kohli
Daljeet Kohli of IndiaNivesh has released a detailed report setting out the best pharma stocks to buy now
Recent Comments